Fetal Penile Length and Corpus Cavernosum Length - Normal Measurement Via Ultrasound

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2010 by Tel-Aviv Sourasky Medical Center.
Recruitment status was Not yet recruiting

Sponsor:

Information provided by:

Tel-Aviv Sourasky Medical Center

ClinicalTrials.gov Identifier:

NCT01114867

First received: April 29, 2010

Last updated: April 30, 2010

Last verified: April 2010

History of Changes

Tracking Information

First Received Date ^ICMJE

April 29, 2010

Last Updated Date

April 30, 2010

Start Date ^ICMJE

May 2010

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT01114867 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Fetal Penile Length and Corpus Cavernosum Length - Normal Measurement Via Ultrasound

Official Title ^ICMJE

Prospective Cross-sectional Study of Fetal Penis and Corpus Cavernosum Length

Brief Summary

Hypothesis: Measurement of fetal penis length by ultrasound may be inaccurate when measured from the scrotum to the penile tip. we will provide normal values of penile length measured from the penile tip to the abdominal wall and measuring the corpus cavernosum length.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Case Control
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

Fetuses of healthy pregnant women

Condition ^ICMJE

Fetal Penis Length

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Not yet recruiting

Estimated Enrollment ^ICMJE

200

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

pregnant women at 14th through 34th week gestation,
routine ultrasound not preformed for anomalies at the genitourinary system,
estimated fetal weight corresponds to gestational age.

Exclusion Criteria:

women who's fetuses are suspected to be with fetal growth retardation,
women who's fetuses are suspected to be with genitourinary anomaly.

Gender

Male

Ages

14 Weeks to 34 Weeks

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Not Provided

Location Countries ^ICMJE

Israel

Administrative Information

NCT Number ^ICMJE

NCT01114867

Other Study ID Numbers ^ICMJE

TASMC-10-YH-0128-CTIL

Has Data Monitoring Committee

Responsible Party

Yoseph Hartoov / Dr, Sorasky Medical Center

Study Sponsor ^ICMJE

Tel-Aviv Sourasky Medical Center

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Yoseph Hartoov, Dr

Tel-Aviv, Soraski Medical Center

Information Provided By

Tel-Aviv Sourasky Medical Center

Verification Date

April 2010

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top